Benedict Financial Advisors Inc Novo Nordisk A S Transaction History

Benedict Financial Advisors Inc

$410 Million
Q4 2024

A detailed history of Benedict Financial Advisors Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Benedict Financial Advisors Inc holds 38,551 shares of NVO stock, worth $2.41 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

38,551

Previous 40,065 3.78%

Holding current value

$2.41 Million

Previous $4.77 Million 30.48%

% of portfolio

0.81%

Previous 1.13%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$85.0 - $120.04 $128,690 - $181,740	-1,514 Reduced 3.78%	38,551 $3.32 Million
Q3 2024 Oct 24, 2024	SELL	$119.07 - $145.42 $158,720 - $193,844	-1,333 Reduced 3.22%	40,065 $4.77 Million
Q2 2024 Jul 30, 2024	SELL	$122.71 - $146.91 $153,142 - $183,343	-1,248 Reduced 2.93%	41,398 $5.91 Million
Q1 2024 Apr 25, 2024	SELL	$102.11 - $135.92 $103,947 - $138,366	-1,018 Reduced 2.33%	42,646 $5.48 Million
Q4 2023 Jan 29, 2024	SELL	$87.78 - $105.45 $55,125 - $66,222	-628 Reduced 1.42%	43,664 $4.52 Million
Q3 2023 Oct 18, 2023	BUY	$90.94 - $199.54 $1.95 Million - $4.28 Million	21,457 Added 93.97%	44,292 $4.03 Million
Q2 2023 Aug 10, 2023	SELL	$155.98 - $172.65 $53,657 - $59,391	-344 Reduced 1.48%	22,835 $3.7 Million
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $193,613 - $232,821	-1,463 Reduced 5.94%	23,179 $3.69 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $36,405 - $48,042	-355 Reduced 1.42%	24,642 $3.33 Million
Q3 2022 Nov 07, 2022	SELL	$95.28 - $116.93 $15,149 - $18,591	-159 Reduced 0.63%	24,997 $2.49 Million
Q2 2022 Jul 28, 2022	SELL	$103.24 - $121.81 $21,577 - $25,458	-209 Reduced 0.82%	25,156 $2.8 Million
Q1 2022 May 03, 2022	SELL	$93.1 - $112.54 $21,878 - $26,446	-235 Reduced 0.92%	25,365 $2.82 Million
Q4 2021 Feb 09, 2022	SELL	$95.88 - $117.08 $64,814 - $79,146	-676 Reduced 2.57%	25,600 $2.87 Million
Q3 2021 Oct 29, 2021	SELL	$84.42 - $106.62 $28,871 - $36,464	-342 Reduced 1.28%	26,276 $2.52 Million
Q2 2021 Aug 05, 2021	BUY	$67.66 - $84.76 $69,554 - $87,133	1,028 Added 4.02%	26,618 $2.23 Million
Q1 2021 May 10, 2021	BUY	$67.06 - $75.82 $35,474 - $40,108	529 Added 2.11%	25,590 $1.73 Million
Q4 2020 Feb 02, 2021	BUY	$63.89 - $73.8 $53,667 - $61,992	840 Added 3.47%	25,061 $1.75 Million
Q3 2020 Nov 03, 2020	BUY	$63.69 - $70.22 $34,965 - $38,550	549 Added 2.32%	24,221 $1.68 Million
Q2 2020 Jul 23, 2020	BUY	$58.54 - $67.94 $120,124 - $139,412	2,052 Added 9.49%	23,672 $1.55 Million
Q1 2020 Apr 21, 2020	BUY	$49.46 - $64.78 $451,322 - $591,117	9,125 Added 73.03%	21,620 $1.3 Million
Q4 2019 Feb 04, 2020	BUY	$49.86 - $58.26 $623,000 - $727,958	12,495 New	12,495 $723,000

Others Institutions Holding NVO

# of Institutions

1,852

Shares Held

338M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $141B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedict Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benedict Financial Advisors Inc with notifications on news.

Account

Benedict Financial Advisors Inc Novo Nordisk A S Transaction History